Trinity Financial Advisors’s AbbVie ABBV Stock Holding History

Trinity Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$269K	Buy	1,071 +53	+5%	+$11.4K	0.07%	81
2026 Q1	$221K	Buy	1,018 +2	+0.2%	+$444	0.06%	84
2025 Q4	$232K	Sell	1,016 -127	-11%	-$28.9K	0.06%	87
2025 Q3	$265K	Buy	+1,143	New	+$233K	0.08%	85
2024 Q1	–	Sell	-1,298	Closed	-$201K	–	74
2023 Q4	$201K	Sell	1,298 -2,089	-62%	-$305K	0.1%	73
2023 Q3	$505K	Sell	3,387 -754	-18%	-$111K	0.27%	36
2023 Q2	$558K	Sell	4,141 -921	-18%	-$135K	0.3%	32
2023 Q1	$807K	Buy	5,062 +751	+17%	+$115K	0.49%	19
2022 Q4	$697K	Buy	4,311 +282	+7%	+$43.2K	0.46%	25
2022 Q3	$541K	Buy	+4,029	New	+$578K	0.39%	31

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Trinity Financial Advisors's ABBV Position: Q2 2026 in Review

Trinity Financial Advisors increased its AbbVie (ABBV) stake by 5.2% in Q2 2026, buying an estimated $11.4K and bringing the position to 1,071 shares worth $269K. The position accounts for 0.07% of the portfolio, ranked #81.

Trinity Financial Advisors first reported a position in ABBV in Q3 2022 and has held it in 10 quarters since. The position peaked at $807K in Q1 2023. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Trinity Financial Advisors held 1,071 shares of AbbVie worth $269K as of Q2 2026.
Trinity Financial Advisors bought 53 AbbVie shares in Q2 2026, an estimated $11.4K.
AbbVie made up 0.07% of Trinity Financial Advisors's portfolio in Q2 2026, its #81 holding.
Trinity Financial Advisors first reported a position in AbbVie in Q3 2022 and has held it in 10 quarters since.
Trinity Financial Advisors's AbbVie position peaked at $807K in Q1 2023.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Trinity Financial Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.